Phase I Trial of Interferon Alfa-n3 in Early-Stage Human Immunodeficiency Virus Type 1 Disease: Evidence for Drug Safety, Tolerance, and Antiviral Activity

Autor:	Skillman, Donald R., Malone, Joseph L., Decker, Catherine F., Wagner, Kenneth F., Mapou, Robert L., Liao, Mei-June, Testa, Douglas, Meltzer, Monte S.
Zdroj:	The Journal of Infectious Diseases, 1996 May 01. 173(5), 1107-1114.
Databáze:	JSTOR Journals
Externí odkaz:	https://www.jstor.org/stable/30123010 Zobrazit plný text záznamu